Healthcare -
Biotechnology - NASDAQ - US
$ 39.21
-0.835 %
$ 3.85 B
Market Cap
-14.85
P/E
SRPT - NET INCOME
Net Income SRPT - Sarepta Therapeutics, Inc.
235 M
LAST VALUE
52.79%
2 YEAR CAGR
18.42%
5 YEAR CAGR
14.08%
10 YEAR CAGR